Beximco Pharmaceuticals Ltd. (“BPL” or the “Company”), the leading pharmaceutical manufacturer and the largest exporter of pharmaceutical products from Bangladesh, today announces that it has commenced exports to Chile, after receiving marketing authorization for a number of products from “Instituto de Salud Publica de Chile” (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country.
Chile is the sixth largest pharmaceutical market in Latin America. In 2007, the Chilean pharmaceutical market was valued at US$1.5 billion.
Beximco Pharma CEO Mr. Nazmul Hassan said: “Our entry into Latin America marks another milestone in the Company’s plan to become a global pharmaceutical company. With a market size of around US$40 billion and with a high growth rate, Latin America is considered as one of the biggest pharmaceutical markets and it is strategically important for us in our global expansion program. Being successful in registering our products in Chile will mark our presence in the region. We continue to seek similar opportunities and are actively working in other Latin American countries.”
For further enquiries please contact:
Beximco Pharma Nazmul Hassan, CEO Tel: +880 2 861 9151, ext.2080
Libertas Capital Aamir Quraishi / Andrew Hardy Tel: +44 (0)20 7569 9650
Financial Dynamics David Yates / Susan Quigley Tel: +44 (0)20 7269 7169
